Shilpa Medicare facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (Andhra Pradesh) has become operational.
The company’s new facility is to take up for Contract Research and Forward Integration, that is, own formulation (manufacturing of oral and injectible (for onco products).
“Facility for manufacture of formulation section will commence commercial production in stages after successful completion of trial production/stability tests which is under way,” a senior company official said.
The company had visualised contract research as one of the thrust area few years back. It invested in creating research and development centres at two places.
Such investment has started yielding results. It expects that this will grow in time to come and would become an important source of income, besides inventing new/improved products for the company.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.